AU2003288107A1 - Tiotropium-containing medicament combinations used for inhaling - Google Patents

Tiotropium-containing medicament combinations used for inhaling

Info

Publication number
AU2003288107A1
AU2003288107A1 AU2003288107A AU2003288107A AU2003288107A1 AU 2003288107 A1 AU2003288107 A1 AU 2003288107A1 AU 2003288107 A AU2003288107 A AU 2003288107A AU 2003288107 A AU2003288107 A AU 2003288107A AU 2003288107 A1 AU2003288107 A1 AU 2003288107A1
Authority
AU
Australia
Prior art keywords
inhaling
tiotropium
combinations used
containing medicament
medicament combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003288107A
Inventor
Ingo Konetzki
Christopher John Montague Meade
Michel Pairet
Michael P. Pieper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BOEHRINGER INGELHEIM PHARMA, Boehringer Ingelheim Pharma GmbH and Co KG filed Critical BOEHRINGER INGELHEIM PHARMA
Publication of AU2003288107A1 publication Critical patent/AU2003288107A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to novel medicaments used for inhaling, comprising one or several, preferably one, tiotropium salt in combination with one or several pharmaceutically acceptable acid addition salts of a compound of formula 2', wherein radicals R<1>, R<2>, R<3>, and R<4> can have the meanings indicated in the description and in the claims. Also disclosed are methods for the production thereof and the use thereof in the therapy of respiratory diseases.
AU2003288107A 2002-11-29 2003-11-19 Tiotropium-containing medicament combinations used for inhaling Abandoned AU2003288107A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10256080.3 2002-11-29
DE10256080A DE10256080A1 (en) 2002-11-29 2002-11-29 Combination medicinal product for inhalation containing tiotropium
PCT/EP2003/012913 WO2004050093A1 (en) 2002-11-29 2003-11-19 Tiotropium-containing medicament combinations used for inhaling

Publications (1)

Publication Number Publication Date
AU2003288107A1 true AU2003288107A1 (en) 2004-06-23

Family

ID=32318866

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003288107A Abandoned AU2003288107A1 (en) 2002-11-29 2003-11-19 Tiotropium-containing medicament combinations used for inhaling

Country Status (9)

Country Link
EP (1) EP1581224B1 (en)
JP (1) JP4850415B2 (en)
AT (1) ATE384531T1 (en)
AU (1) AU2003288107A1 (en)
CA (1) CA2507656C (en)
DE (2) DE10256080A1 (en)
DK (1) DK1581224T3 (en)
ES (1) ES2298597T3 (en)
WO (1) WO2004050093A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1938822A1 (en) * 2006-12-21 2008-07-02 Novartis AG Combination therapy for the treatment of airways disease
NZ605920A (en) * 2010-07-16 2015-01-30 Cipla Ltd Pharmaceutical compositions comprising r (+) budesonide and one or more bronchodilators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9913083D0 (en) * 1999-06-04 1999-08-04 Novartis Ag Organic compounds
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
DE10056104A1 (en) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Drug compositions useful for treatment of respiratory diseases, especially asthma and chronic obstructive pulmonary disease comprises tiotropium salts and salmeterol salts

Also Published As

Publication number Publication date
EP1581224B1 (en) 2008-01-23
ES2298597T3 (en) 2008-05-16
DE10256080A1 (en) 2004-06-17
WO2004050093A1 (en) 2004-06-17
DE50309096D1 (en) 2008-03-13
JP4850415B2 (en) 2012-01-11
ATE384531T1 (en) 2008-02-15
JP2006509776A (en) 2006-03-23
EP1581224A1 (en) 2005-10-05
CA2507656A1 (en) 2004-06-17
CA2507656C (en) 2011-07-12
DK1581224T3 (en) 2008-03-25

Similar Documents

Publication Publication Date Title
WO2004037807A3 (en) Medicinal arylethanolamine compounds
UA85708C2 (en) Benzoxazine-containing pharmaceutical combinations for treating respiratory tract diseases
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
RS20090083A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta -mimetics
WO2004045618A3 (en) Novel medicaments for the treatment of chronic obstructive pulmonary diseases
MY148108A (en) Medicaments for the treatment or prevention of fibrotic diseases
BG108318A (en) Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments
SE0202462D0 (en) Novel use
WO2002070510A3 (en) Amino dicarboxylic acid derivatives with pharmaceutical properties
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
NO20055655D0 (en) Use of azetidinecarboxamide derivatives in therapy
UA83233C2 (en) Substituted 2-aminotetralin for the treatment of depression
HRP20040944B1 (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
WO2002088100A3 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
MXPA06013221A (en) Inhalation powder formulations containing enantiomerically pure beta-agonists.
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
TW200531688A (en) Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
WO2003087049A3 (en) Pharmaceutical combinations containing heterocyclic compounds and a novel anticholinergic agent
MXPA05005790A (en) Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders.
NZ547523A (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
SG137859A1 (en) Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
RS89904A (en) Medicaments containing steroids and a novel anticholinesterase drug
MXPA04002401A (en) Novel medicaments for inhalation.
AU2003288107A1 (en) Tiotropium-containing medicament combinations used for inhaling
TW200612914A (en) Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase